PHK
PRTK

Point72 Hong Kong’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Point72 Hong Kong’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,651
Closed -$5K – 2535
2022
Q1 		$5K Buy
+1,651
New +$6.21K ﹤0.01% 1689
2016
Q4 		– Sell
-100
Closed -$1K – 1082
2016
Q3 		$1K Buy
+100
New +$1.33K ﹤0.01% 715

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Point72 Hong Kong's PRTK Position: Q2 2022 in Review

Point72 Hong Kong sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2022, closing a stake of 1,651 shares — an estimated $5K sold.

Point72 Hong Kong first reported a position in PRTK in Q3 2016 and held it in 2 quarters. The position peaked at $5K in Q1 2022. 84 funds tracked by Wall St. Rank hold PRTK as of Q2 2022.

  • Point72 Hong Kong reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,651 Paratek Pharmaceuticals, Inc. shares in Q2 2022, an estimated $5K.
  • Point72 Hong Kong first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • Point72 Hong Kong's Paratek Pharmaceuticals, Inc. position peaked at $5K in Q1 2022.
  • 84 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.